Neurology Updates

The study validated a screening questionnaire for pediatric narcolepsy, which showed high sensitivity and specificity in identifying affected…

A “Mini Linguistic State Examination”, was developed to assess and classify language disorders in patients with primary progressive aphasia (PPA).…

Rozanolixizumab is subcutaneous infused monoclonal antibody targeting the neonatal Fc receptor (FcRn) in adult with MG.

As already presented…

An interim analysis of the phase 3 open-label extension study (RAISE-XT) testing zilucoplan (a self-administered subcutaneous complement C5 inhibitor)…

Eculizumab (Soliris; Alexion) is an intravenous complement C5 inhibitor originally approved by FDA and EMA in adult’s patient with anti-acetylcholine…

Deep intronic GAA-expansions in the FGF14 gene have been recently identified as a common cause of late onset cerebellar ataxia, a disease entity that…

A large study on 147 patients with antibody negative autoimmune encephalitis defines long term outcome and provides important clues on treatment…

Thermoregulatory abnormalities are known to occur in demyelinating disorders, yet they are poorly studied (Adamec et al 2018). While a few studies…

Arbab et al. (2023) showed for the first time the feasibility of genome editing as permanently restoring SMN protein levels in cellular and animal…

A GAA repeat expansion in FGF14 appears to be an important and frequent cause of autosomal dominant late-onset cerebellar ataxia, further expanding…

WGS can reliably assess the most common neurological disease-causing repeat expansions, further supporting its implementation in clinical practice

The world has changed for patients and parents of children suffering from spinal muscular atrophy (SMA) type 1. Without treatment these children…